PCN Insights, News, Videos, and More

Elevated depression symptoms are associated with insulin resistance measured by steady-state plasma glucose, according to findings presented at the virtual 2021 American Psychiatric Association Annual Meeting.

Wesana Health Holdings this week announced that it is teaming with the World Boxing Council on a multi-year clinical research project to examine the potential of psilocybin-assisted therapy to reduce effects and symptoms of traumatic brain...

A newly identified psychedelic that doesn’t trigger hallucinations could facilitate significant progress in the development of treatments for mental health conditions. Studying hallucinogenic and non-hallucinogenic psychedelics,...

Notwithstanding a lack of clinical evidence supporting the practice, a notable percentage of psychiatrists said they would use an anticholinergic medication to manage symptoms of tardive dyskinesia in a patient. Researchers presented their...

A new analysis of the EAGLES study found moderate to strong evidence that the smoking cessation drug varenicline does not increase the risk of neuropsychiatric adverse events in people without pre-existing psychiatric conditions.

An oral dissolving film for sublingual or buccal administration of dexmedetomidine was effective and well-tolerated for the rapid treatment of acute agitation in patients with schizophrenia, according to a poster presented at the 2021 APA...

Adult psychiatric outpatients with attention-deficit/hyperactivity disorder (ADHD) had higher levels of uncertainty intolerance compared with outpatients without ADHD, according to a poster presented at the virtual 2021 APA Meeting.

Reports of anxiety and depression rose to a significant 50% and 44%, respectively, among US residents during the first 9 months of the COVID-19 pandemic, according to study results published online in Translational Behavioral Medicine.